135 related articles for article (PubMed ID: 332054)
21. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
[TBL] [Abstract][Full Text] [Related]
22. Bromocriptine therapy in acromegaly.
Sachdev Y; Gomez-Pan A; Tunbridge WM; Duns A; Weightman DR; Hall R; Goolamali SK
Lancet; 1975 Dec; 2(7946):1164-8. PubMed ID: 53655
[TBL] [Abstract][Full Text] [Related]
23. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
Giustina A; Doga M; Bussi AR; Licini M; Schettino M
Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
[TBL] [Abstract][Full Text] [Related]
24. [Bromocriptin treatment of acromegaly (author's transl)(proceedings)].
Bricaire H; Strauch G; Boutonnat Y
Ann Endocrinol (Paris); 1976; 37(4):301-2. PubMed ID: 1037361
[No Abstract] [Full Text] [Related]
25. Long-term bromocriptine therapy and predictive tests in acromegaly.
Karashima T; Kato K; Nawata H; Ikuyama S; Ibayashi H; Okamura K; Shiroozu A; Nakashima T; Fujishima M
Endocrinol Jpn; 1986 Apr; 33(2):163-7. PubMed ID: 3093202
[TBL] [Abstract][Full Text] [Related]
26. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Yamamoto M; Kumagai A
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):636-47. PubMed ID: 99332
[TBL] [Abstract][Full Text] [Related]
27. Effect of the acute administration of haloperidol and pimozide on plasma GH levels in acromegaly.
Carmina E; Lo Coco R; Lanzara P; Jannì A
Acta Endocrinol (Copenh); 1979 Aug; 91(4):609-15. PubMed ID: 115193
[TBL] [Abstract][Full Text] [Related]
28. Bromocriptine treatment in acromegaly: clinical and biochemical effects.
Halse J; Haugen HN; Bohmer T
Acta Endocrinol (Copenh); 1977 Nov; 86(3):464-72. PubMed ID: 335755
[TBL] [Abstract][Full Text] [Related]
29. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
30. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests.
Nortier JW; Croughs RJ; Thijssen JH; Schwarz F
Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634
[TBL] [Abstract][Full Text] [Related]
31. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
Nilsson A
Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
[TBL] [Abstract][Full Text] [Related]
32. Bromocriptine reduces growth hormone in acromegaly.
Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
[TBL] [Abstract][Full Text] [Related]
33. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
Dolecek R
Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
[No Abstract] [Full Text] [Related]
34. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
[TBL] [Abstract][Full Text] [Related]
35. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
[TBL] [Abstract][Full Text] [Related]
36. No acute effect of pimozide on the plasma GH levels in acromegaly.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Aug; 103(4):461-8. PubMed ID: 6613492
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
Plöckinger U; Quabbe HJ
J Endocrinol Invest; 1991 Dec; 14(11):943-8. PubMed ID: 1806612
[TBL] [Abstract][Full Text] [Related]
38. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
Belforte L; Camanni F; Chiodini PG; Liuzzi A; Massara F; Molinatti GM; Müller EE; Silvestrini F
Acta Endocrinol (Copenh); 1977 Jun; 85(2):235-48. PubMed ID: 405832
[TBL] [Abstract][Full Text] [Related]
40. Treatment of acromegaly with bromocryptine.
Summers VK; Hipkin LJ; Diver MH; Davis JC
J Clin Endocrinol Metab; 1975 May; 40(5):904-6. PubMed ID: 1127097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
